Stressors Affect Systemic Inflammation, Tumor Aggressiveness in Breast Cancer
By Elana Gotkine HealthDay Reporter
THURSDAY, Feb. 27, 2025 -- For women with breast cancer, stressors are associated with deleterious alterations to the systemic and tumor immune environment, according to a study published online Feb. 14 in JAMA Network Open.
Alexandra R. Harris, Ph.D., M.P.H., from the National Institutes of Health in Bethesda, Maryland, and colleagues examined the proteomic, transcriptomic, and genomic effects associated with multilevel chronic stressors in Black and White women with breast cancer (56 and 65 women, respectively) recruited from two hospitals.
The analytic subsample included 117 blood samples, 48 breast tumors, and 41 adjacent noncancerous tissues. The researchers found that levels of perceived stress and social support were comparable by race, but Black women resided in more socioeconomically deprived neighborhoods. More favorable immune-stimulatory changes were seen in association with greater perceived social support (e.g., increased serum interleukin-5 and activated natural killer cells in noncancerous breast tissue of Black women). Associations were seen for higher levels of perceived stress, exposure to discrimination, and neighborhood deprivation with systemic inflammation, deleterious immune cell profiles, and aggressive tumor biologic characteristics. Distinct immunologic features associated with stressors were identified in Black women, including chemotaxis with stress and immune suppression with stress at the systemic level and increased tumor-associated myeloid cells at the tissue level. An association was seen for perceived stress with elevated tumor mutational burden.
"Understanding biology as a possible mediator of cancer health disparities can inform prevention and public health interventions," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
One-Week Radiotherapy for Breast Cancer Safe, Effective Up to 10 Years
TUESDAY, May 27, 2025 -- A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule for patients with invasive...
Artificial Intelligence Flags Interval Breast Cancers Visible at Screening
FRIDAY, May 23, 2025 -- Artificial intelligence (AI) more often flags and accurately localizes interval breast cancers (IBCs) that are visible at screening than true interval or...
Abbreviated Breast MRI Has High Diagnostic Accuracy for Dense Breasts
THURSDAY, May 22, 2025 -- For women with extremely dense breasts who are negative for cancer at mammography, abbreviated breast magnetic resonance imaging (MRI) for first-round...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.